Meropenem Farmalider

Meropenem, the active ingredient in Meropenem Farmalider, is a carbapenem antibiotic presented as an oral formulation for systemic use. It treats severe bacterial infections such as intra‑abdominal, urinary tract, pulmonary and bloodstream infections in adult patients.

GNH USA supplies Meropenem Farmalider as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide. The company adheres to EU quality standards and provides reliable sourcing for healthcare institutions.

Meropenem is a broad‑spectrum carbapenem used to treat serious bacterial infections in various organ systems.

- Complicated intra‑abdominal infections: provides bacterial eradication in severe abdominal infections. - Complicated urinary tract infections: clears resistant uropathogens causing kidney and bladder infections. - Nosocomial pneumonia: treats hospital‑acquired lung infections caused by multidrug‑resistant bacteria. - Sepsis: rapidly eliminates bloodstream pathogens in systemic infection. - Skin and soft tissue infections: resolves deep tissue infections when other agents fail.

Meropenem may be associated with a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Diarrhea: may be watery and self‑limiting. - Vomiting: occasional episodes after dosing. - Headache: transient cranial discomfort. - Rash: mild skin erythema. - Elevated liver enzymes: transient increase in transaminases.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Clostridioides difficile colitis: severe intestinal inflammation. - Seizures: especially in patients with renal impairment or high doses. - Acute renal failure: rapid decline in kidney function. - Hepatotoxicity: significant liver injury in rare cases.

When prescribing Meropenem, clinicians should consider several safety and handling precautions.

- Renal function: adjust dose in patients with impaired kidney function. - Allergy history: avoid in patients with known carbapenem hypersensitivity. - Concomitant antibiotics: assess for additive toxicity, especially nephrotoxic agents. - Pregnancy and lactation: use only if benefit outweighs potential risk. - Microbial resistance: reserve for infections caused by resistant organisms to limit resistance development. - Store at below 25°C: keep in the original container, protect from moisture and light.

Meropenem can interact with other medicines, affecting efficacy or safety.

Major Interactions (Avoid): - Valproic acid: may reduce serum levels, increasing seizure risk. - Probenecid: can raise meropenem concentrations, heightening toxicity. - Cytotoxic agents: potential additive nephrotoxicity.

Moderate Interactions (Monitor Closely): - Aminoglycosides: monitor renal function due to combined nephrotoxic potential. - Loop diuretics: watch for electrolyte disturbances. - Anticoagulants: monitor INR or PT/INR values for altered anticoagulant effect.